BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van de Wall S, Santegoets KC, van Houtum EJ, Büll C, Adema GJ. Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment. Trends in Immunology 2020;41:274-85. [DOI: 10.1016/j.it.2020.02.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee DH, Kang SH, Choi DS, Ko M, Choi E, Ahn H, Min H, Oh SJ, Lee MS, Park Y, Jin HS. Genome wide CRISPR screening reveals a role for sialylation in the tumorigenesis and chemoresistance of acute myeloid leukemia cells. Cancer Lett 2021;510:37-47. [PMID: 33872695 DOI: 10.1016/j.canlet.2021.04.006] [Reference Citation Analysis]
2 Manni M, Läubli H. Targeting glyco-immune checkpoints for cancer therapy. Expert Opin Biol Ther 2021;21:1063-71. [PMID: 33502268 DOI: 10.1080/14712598.2021.1882989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 da Fonseca LM, da Silva VA, da Costa KM, dos Reis JS, Previato JO, Previato LM, Freire-de-lima L. Resistance to cisplatin in human lung adenocarcinoma cells: effects on the glycophenotype and epithelial to mesenchymal transition markers. Glycoconj J. [DOI: 10.1007/s10719-022-10042-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Benmerzoug S, Chevalier MF, Villier L, Nguyen S, Cesson V, Schneider AK, Dartiguenave F, Rodrigues-Dias SC, Lucca I, Jichlinski P, Roth B, Nardelli-Haefliger D, Derré L. Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer Patients. Eur Urol Open Sci 2021;34:79-82. [PMID: 34825225 DOI: 10.1016/j.euros.2021.10.001] [Reference Citation Analysis]
5 Kho VM, Mekers VE, Span PN, Bussink J, Adema GJ. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment. Cell Immunol 2021;362:104298. [PMID: 33592541 DOI: 10.1016/j.cellimm.2021.104298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Szczykutowicz J, Tkaczuk-Włach J, Ferens-Sieczkowska M. Glycoproteins Presenting Galactose and N-Acetylgalactosamine in Human Seminal Plasma as Potential Players Involved in Immune Modulation in the Fertilization Process. Int J Mol Sci 2021;22:7331. [PMID: 34298952 DOI: 10.3390/ijms22147331] [Reference Citation Analysis]
7 Islam M, Arlian BM, Pfrengle F, Duan S, Smith SA, Paulson JC. Suppressing Immune Responses Using Siglec Ligand-Decorated Anti-receptor Antibodies. J Am Chem Soc 2022;144:9302-11. [PMID: 35593593 DOI: 10.1021/jacs.2c00922] [Reference Citation Analysis]
8 Lamprinaki D, Garcia-Vello P, Marchetti R, Hellmich C, McCord KA, Bowles KM, Macauley MS, Silipo A, De Castro C, Crocker PR, Juge N. Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated Fusobacterium nucleatum ssp. animalis. Front Immunol 2021;12:744184. [PMID: 34659241 DOI: 10.3389/fimmu.2021.744184] [Reference Citation Analysis]
9 Lai Z, Zhang M, Zhou J, Chen T, Li D, Shen X, Liu J, Zhou J, Li Z. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides. Analyst 2021;146:4261-7. [PMID: 34105527 DOI: 10.1039/d1an00580d] [Reference Citation Analysis]
10 Chen Z, Xu SL, Ge LY, Zhu J, Zheng T, Zhu Z, Zhou L. Sialic acid-binding immunoglobulin-like lectin 9 as a potential therapeutic target for chronic obstructive pulmonary disease. Chin Med J (Engl) 2021;134:757-64. [PMID: 33595976 DOI: 10.1097/CM9.0000000000001381] [Reference Citation Analysis]
11 Wielgat P, Niemirowicz-Laskowska K, Wilczewska AZ, Car H. Sialic Acid-Modified Nanoparticles-New Approaches in the Glioma Management-Perspective Review. Int J Mol Sci 2021;22:7494. [PMID: 34299113 DOI: 10.3390/ijms22147494] [Reference Citation Analysis]
12 van den Bijgaart RJE, Schuurmans F, Fütterer JJ, Verheij M, Cornelissen LAM, Adema GJ. Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ. Front Immunol 2021;12:617365. [PMID: 33936033 DOI: 10.3389/fimmu.2021.617365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Friedman DJ, Crotts SB, Shapiro MJ, Rajcula M, McCue S, Liu X, Khazaie K, Dong H, Shapiro VS. ST8Sia6 Promotes Tumor Growth in Mice by Inhibiting Immune Responses. Cancer Immunol Res 2021;9:952-66. [PMID: 34074677 DOI: 10.1158/2326-6066.CIR-20-0834] [Reference Citation Analysis]
14 van Houtum EJH, Büll C, Cornelissen LAM, Adema GJ. Siglec Signaling in the Tumor Microenvironment. Front Immunol 2021;12:790317. [PMID: 34966391 DOI: 10.3389/fimmu.2021.790317] [Reference Citation Analysis]
15 Ding J, Sui D, Liu M, Su Y, Wang Y, Liu M, Luo X, Liu X, Deng Y, Song Y. Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil/monocyte infiltration for tumor therapy. Acta Biomater 2021;134:702-15. [PMID: 34339869 DOI: 10.1016/j.actbio.2021.07.063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
16 Tang F, Zhang L, Xu L, Zou Q, Feng H. The accurate prediction and characterization of cancerlectin by a combined machine learning and GO analysis. Brief Bioinform 2021:bbab227. [PMID: 34113984 DOI: 10.1093/bib/bbab227] [Reference Citation Analysis]
17 Salminen A, Kaarniranta K, Kauppinen A. Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: Potential role in Alzheimer's pathogenesis. Neurochem Int 2021;150:105186. [PMID: 34530055 DOI: 10.1016/j.neuint.2021.105186] [Reference Citation Analysis]
18 Visser EA, Moons SJ, Timmermans SBPE, de Jong H, Boltje TJ, Büll C. Sialic acid O-acetylation: From biosynthesis to roles in health and disease. J Biol Chem 2021;297:100906. [PMID: 34157283 DOI: 10.1016/j.jbc.2021.100906] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Meril S, Harush O, Reboh Y, Matikhina T, Barliya T, Cohen CJ. Targeting glycosylated antigens on cancer cells using siglec‐7/9‐based CAR T‐cells. Molecular Carcinogenesis 2020;59:713-23. [DOI: 10.1002/mc.23213] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
20 Büll C, Nason R, Sun L, Van Coillie J, Madriz Sørensen D, Moons SJ, Yang Z, Arbitman S, Fernandes SM, Furukawa S, McBride R, Nycholat CM, Adema GJ, Paulson JC, Schnaar RL, Boltje TJ, Clausen H, Narimatsu Y. Probing the binding specificities of human Siglecs by cell-based glycan arrays. Proc Natl Acad Sci U S A 2021;118:e2026102118. [PMID: 33893239 DOI: 10.1073/pnas.2026102118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
21 Chen Z, Yu M, Guo L, Zhang B, Liu S, Zhang W, Zhou B, Yan J, Ma Q, Yang Z, Xiao Y, Xu Y, Li H, Ye Q. Tumor Derived SIGLEC Family Genes May Play Roles in Tumor Genesis, Progression, and Immune Microenvironment Regulation. Front Oncol 2020;10:586820. [PMID: 33240817 DOI: 10.3389/fonc.2020.586820] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Cotton S, Ferreira D, Soares J, Peixoto A, Relvas-Santos M, Azevedo R, Piairo P, Diéguez L, Palmeira C, Lima L, Silva AMN, Lara Santos L, Ferreira JA. Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness. Int J Mol Sci 2021;22:1664. [PMID: 33562270 DOI: 10.3390/ijms22041664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Zhang E, Wen S, Quan J, Han J, Cao H, Han S. Installation of high-affinity Siglec-1 ligand on tumor surface for macrophage-engaged tumor suppression. Bioorg Med Chem Lett 2021;50:128328. [PMID: 34425200 DOI: 10.1016/j.bmcl.2021.128328] [Reference Citation Analysis]
24 Li T, Jin K, Li H, Ye L, Li P, Jiang B, Lin X, Liao Z, Zhang H, Shi S, Lin M, Fei Q, Xiao Z, Xu H, Liu L, Yu X, Wu W. SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.01.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Benmerzoug S, Chevalier MF, Verardo M, Nguyen S, Cesson V, Schneider AK, Dartiguenave F, Rodrigues-Dias SC, Lucca I, Jichlinski P, Roth B, Nardelli-Haefliger D, Derré L. Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients. Eur Urol Focus 2021:S2405-4569(21)00163-2. [PMID: 34147404 DOI: 10.1016/j.euf.2021.06.001] [Reference Citation Analysis]
26 Røyrvik EC, Husebye ES. The genetics of autoimmune Addison disease: past, present and future. Nat Rev Endocrinol. [DOI: 10.1038/s41574-022-00653-y] [Reference Citation Analysis]
27 Xu Y, Su GH, Ma D, Xiao Y, Shao ZM, Jiang YZ. Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence. Signal Transduct Target Ther 2021;6:312. [PMID: 34417437 DOI: 10.1038/s41392-021-00729-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Rodrigues Mantuano N, Natoli M, Zippelius A, Läubli H. Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy. J Immunother Cancer 2020;8:e001222. [PMID: 33020245 DOI: 10.1136/jitc-2020-001222] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
29 Lenza MP, Atxabal U, Oyenarte I, Jiménez-Barbero J, Ereño-Orbea J. Current Status on Therapeutic Molecules Targeting Siglec Receptors. Cells 2020;9:E2691. [PMID: 33333862 DOI: 10.3390/cells9122691] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
30 Choi Y, Kim J, Chae J, Hong J, Park J, Jeong E, Kim H, Tanaka M, Okochi M, Choi J. Surface glycan targeting for cancer nano-immunotherapy. J Control Release 2022:S0168-3659(22)00004-9. [PMID: 34998918 DOI: 10.1016/j.jconrel.2022.01.004] [Reference Citation Analysis]
31 Hussein D, Dallol A, Quintas R, Schulten HJ, Alomari M, Baeesa S, Bangash M, Alghamdi F, Khan I, ElAssouli MM, Saka M, Carracedo A, Chaudhary A, Abuzenadah A. Overlapping variants in the blood, tissues and cell lines for patients with intracranial meningiomas are predominant in stem cell-related genes. Heliyon 2020;6:e05632. [PMID: 33305042 DOI: 10.1016/j.heliyon.2020.e05632] [Reference Citation Analysis]
32 Hitchcock CL, Povoski SP, Mojzisik CM, Martin EW. Survival Advantage Following TAG-72 Antigen-Directed Cancer Surgery in Patients With Colorectal Carcinoma: Proposed Mechanisms of Action. Front Oncol 2021;11:731350. [DOI: 10.3389/fonc.2021.731350] [Reference Citation Analysis]
33 Deimel LP, Xue X, Sattentau QJ. Glycans in HIV-1 vaccine design – engaging the shield. Trends in Microbiology 2022. [DOI: 10.1016/j.tim.2022.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Zorca CE, Fallahi A, Luo S, Eldeeb MA. Multifaceted targeted protein degradation systems for different cellular compartments. Bioessays 2022;:e2200008. [PMID: 35417040 DOI: 10.1002/bies.202200008] [Reference Citation Analysis]
35 Saad AA. Targeting cancer-associated glycans as a therapeutic strategy in leukemia. All Life 2022;15:378-433. [DOI: 10.1080/26895293.2022.2049901] [Reference Citation Analysis]
36 Rodrigues JG, Duarte HO, Reis CA, Gomes J. Aberrant protein glycosylation in cancer: implications in targeted therapy. Biochem Soc Trans 2021;49:843-54. [PMID: 33704376 DOI: 10.1042/BST20200763] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Liu T, Zong S, Jiang Y, Zhao R, Wang J, Hua Q. Neutrophils Promote Larynx Squamous Cell Carcinoma Progression via Activating the IL-17/JAK/STAT3 Pathway. J Immunol Res 2021;2021:8078646. [PMID: 34938816 DOI: 10.1155/2021/8078646] [Reference Citation Analysis]
38 Li B, Zhang B, Wang X, Zeng Z, Huang Z, Zhang L, Wei F, Ren X, Yang L. Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis. Oncoimmunology 2020;9:1807291. [PMID: 32939323 DOI: 10.1080/2162402X.2020.1807291] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
39 Xiong J, Wang H, Wang Q. Suppressive Myeloid Cells Shape the Tumor Immune Microenvironment. Adv Biol (Weinh) 2021;5:e1900311. [PMID: 33729699 DOI: 10.1002/adbi.201900311] [Reference Citation Analysis]
40 Sun R, Kim AMJ, Lim SO. Glycosylation of Immune Receptors in Cancer. Cells 2021;10:1100. [PMID: 34064396 DOI: 10.3390/cells10051100] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Pally D, Pramanik D, Hussain S, Verma S, Srinivas A, Kumar RV, Everest-Dass A, Bhat R. Heterogeneity in 2,6-Linked Sialic Acids Potentiates Invasion of Breast Cancer Epithelia. ACS Cent Sci 2021;7:110-25. [PMID: 33532574 DOI: 10.1021/acscentsci.0c00601] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
42 Zhang H, Xie Y, Hu Z, Yu H, Xie X, Ye Y, Xu W, Nian S, Yuan Q. Integrative Analysis of the Expression of SIGLEC Family Members in Lung Adenocarcinoma via Data Mining. Front Oncol 2021;11:608113. [PMID: 33796453 DOI: 10.3389/fonc.2021.608113] [Reference Citation Analysis]
43 Rumpret M, von Richthofen HJ, Peperzak V, Meyaard L. Inhibitory pattern recognition receptors. J Exp Med 2022;219:e20211463. [PMID: 34905019 DOI: 10.1084/jem.20211463] [Reference Citation Analysis]
44 Lopes N, Correia VG, Palma AS, Brito C. Cracking the Breast Cancer Glyco-Code through Glycan-Lectin Interactions: Targeting Immunosuppressive Macrophages. Int J Mol Sci 2021;22:1972. [PMID: 33671245 DOI: 10.3390/ijms22041972] [Reference Citation Analysis]
45 Xiao N, Zhu X, Li K, Chen Y, Liu X, Xu B, Lei M, Xu J, Sun HC. Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma. Exp Hematol Oncol 2021;10:36. [PMID: 34112250 DOI: 10.1186/s40164-021-00230-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Makhijani P, Mcgaha TL. Myeloid Responses to Extracellular Vesicles in Health and Disease. Front Immunol 2022;13:818538. [DOI: 10.3389/fimmu.2022.818538] [Reference Citation Analysis]
47 Dobie C, Skropeta D. Insights into the role of sialylation in cancer progression and metastasis. Br J Cancer 2021;124:76-90. [PMID: 33144696 DOI: 10.1038/s41416-020-01126-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]